Deletion of SPAR led to striking phenotypes in vitro and in vivo, including a reduced capacity to adhere to CRC cells, decreased colonization of the normal colon, and a complete loss of the ability to stimulate CRC cell proliferation in vitro and to promote the development of colon tumors in vivo. Here, SPAAR is linked to colorectal carcinoma.